65
Participants
Start Date
October 1, 2013
Primary Completion Date
June 30, 2016
Study Completion Date
July 31, 2016
methylprednisolone
Adult patients who experienced DIH within 3 days after the administration of dexamethasone as an antiemetic were screened. Eligible patients were randomly assigned to receive dexamethasone or methylprednisolone as an antiemetic (randomization phase). In the next cycle of chemotherapy, the dexamethasone group received methylprednisolone and vice versa in the methylprednisolone group (crossover phase).
Gyeongsang National University Hospital, Chiram-dong, Jinju-si
Chungang University Hospital, Dongjak-gu
Gyeongsang National University Hospital
OTHER
Dong-A University Hospital
OTHER
Samsung Medical Center
OTHER
Chung-Ang University
OTHER